{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:23:32Z","timestamp":1769844212635,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T00:00:00Z","timestamp":1444089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.scr.2015.09.016","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T23:41:25Z","timestamp":1444952485000},"page":"584-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Ang\u00e9lique","family":"Lebouvier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Poignard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Coquelin-Salsac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"L\u00e9otot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Jullien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bierling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Galact\u00e9ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Hernigou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Rouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.scr.2015.09.016_bb0005","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00264-008-0584-1","article-title":"Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease","volume":"33","author":"Akinyoola","year":"2009","journal-title":"Int. Orthop."},{"issue":"1","key":"10.1016\/j.scr.2015.09.016_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jcp.20911","article-title":"Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute","volume":"211","author":"Bernardo","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.scr.2015.09.016_bb0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1359\/jbmr.1999.14.3.336","article-title":"Diseases of bone and the stromal cell lineage","volume":"14","author":"Bianco","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.scr.2015.09.016_bb0020","series-title":"Handbook of Adult and Fetal Stem Cells","article-title":"Skeletal stem cells","author":"Bianco","year":"2004"},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biomaterials.2009.09.043","article-title":"Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate","volume":"31","author":"Chevallier","year":"2010","journal-title":"Biomaterials"},{"issue":"17\u201318","key":"10.1016\/j.scr.2015.09.016_bb0030","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1089\/ten.tea.2011.0645","article-title":"In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells","volume":"18","author":"Coquelin","year":"2012","journal-title":"Tissue Eng. A"},{"issue":"7","key":"10.1016\/j.scr.2015.09.016_bb0035","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1359\/jbmr.1999.14.7.1115","article-title":"Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow","volume":"14","author":"D'Ippolito","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.scr.2015.09.016_bb0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.exphem.2011.04.008","article-title":"Bidirectional interactions between bone metabolism and hematopoiesis","volume":"39","author":"Despars","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.scr.2015.09.016_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fimmu.2013.00201","article-title":"Mesenchymal stem cells in tissue repair","volume":"4","author":"Dimarino","year":"2013","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.scr.2015.09.016_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jcp.20391","article-title":"Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications","volume":"205","author":"Doucet","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.scr.2015.09.016_bb0060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1874325000903010032","article-title":"Multifocal joint osteonecrosis in sickle cell disease","volume":"3","author":"Flouzat-Lachaniette","year":"2009","journal-title":"Open Orthop. J."},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.biomaterials.2010.08.101","article-title":"Stem cell homing in musculoskeletal injury","volume":"32","author":"Fong","year":"2011","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.scr.2015.09.016_bb0070","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","article-title":"Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients","volume":"27","author":"Galotto","year":"1999","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.scr.2015.09.016_bb0075","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2106\/00004623-200406000-00006","article-title":"Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study","volume":"86-A","author":"Gangji","year":"2004","journal-title":"J Bone Joint Surg. Am."},{"issue":"1","key":"10.1016\/j.scr.2015.09.016_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ab.2004.02.002","article-title":"An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction","volume":"329","author":"Gregory","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.scr.2015.09.016_bb0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00003086-200212000-00003","article-title":"Treatment of osteonecrosis with autologous bone marrow grafting","volume":"405","author":"Hernigou","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.81B2.8818","article-title":"Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis","volume":"81","author":"Hernigou","year":"1999","journal-title":"J Bone Joint Surg. Br."},{"key":"10.1016\/j.scr.2015.09.016_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1874325000802010062","article-title":"Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease","volume":"2","author":"Hernigou","year":"2008","journal-title":"Open Orthop. J."},{"issue":"12","key":"10.1016\/j.scr.2015.09.016_bb0100","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2106\/JBJS.E.01455","article-title":"The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease","volume":"88","author":"Hernigou","year":"2006","journal-title":"J. Bone Joint Surg. Am."},{"issue":"1","key":"10.1016\/j.scr.2015.09.016_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-5413.45322","article-title":"Cell therapy of hip osteonecrosis with autologous bone marrow grafting","volume":"43","author":"Hernigou","year":"2009","journal-title":"Indian J. Orthop."},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jor.21230","article-title":"Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects","volume":"29","author":"Jager","year":"2011","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.scr.2015.09.016_bb0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.22203\/eCM.v021a37","article-title":"Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells","volume":"21","author":"Janicki","year":"2011","journal-title":"Eur. Cell. Mater."},{"issue":"1","key":"10.1016\/j.scr.2015.09.016_bb0120","first-page":"24","article-title":"Bone regeneration with mesenchymal stem cells","volume":"9","author":"Kon","year":"2012","journal-title":"Clin. Cases Miner. Bone Metab."},{"issue":"1","key":"10.1016\/j.scr.2015.09.016_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.scr.2008.07.007","article-title":"Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions","volume":"2","author":"Kuznetsov","year":"2009","journal-title":"Stem Cell Res."},{"issue":"12","key":"10.1016\/j.scr.2015.09.016_bb0130","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/00007890-200012270-00018","article-title":"Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation","volume":"70","author":"Kuznetsov","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1634\/stemcells.21-2-190","article-title":"Multipotential mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis","volume":"21","author":"Lee","year":"2003","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.scr.2015.09.016_bb0140","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1148\/radiographics.21.4.g01jl23971","article-title":"Sickle cell anemia","volume":"21","author":"Lonergan","year":"2001","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.scr.2015.09.016_bb0145","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.exphem.2007.01.051","article-title":"Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density","volume":"35","author":"Mankani","year":"2007","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.scr.2015.09.016_bb0150","article-title":"Treatment for avascular necrosis of bone in people with sickle cell disease","volume":"5","author":"Marti-Carvajal","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/scrt55","article-title":"Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology","volume":"2","author":"Maumus","year":"2011","journal-title":"Stem Cell Res. Ther."},{"issue":"10","key":"10.1016\/j.scr.2015.09.016_bb0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1023\/B:JMSM.0000046394.53153.21","article-title":"Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells","volume":"15","author":"Mendes","year":"2004","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"21","key":"10.1016\/j.scr.2015.09.016_bb0165","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199111213252104","article-title":"Sickle cell disease as a cause of osteonecrosis of the femoral head","volume":"325","author":"Milner","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.scr.2015.09.016_bb0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/030097498442235","article-title":"Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors","volume":"27","author":"Oreffo","year":"1998","journal-title":"Scand. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.scr.2015.09.016_bb0175","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/jcb.24166","article-title":"Functional heterogeneity of mesenchymal stem cells: implications for cell therapy","volume":"113","author":"Phinney","year":"2012","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.scr.2015.09.016_bb0180","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2106\/JBJS.J.00919","article-title":"The natural progression of symptomatic humeral head osteonecrosis in adults with sickle cell disease","volume":"94","author":"Poignard","year":"2012","journal-title":"J. Bone Joint Surg. Am."},{"issue":"9079","key":"10.1016\/j.scr.2015.09.016_bb0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(97)07330-3","article-title":"Sickle-cell disease","volume":"350","author":"Serjeant","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.scr.2015.09.016_bb0190","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.joms.2012.12.004","article-title":"Sickle cell disease and perioperative considerations: review and retrospective report","volume":"71","author":"Stanley","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"3","key":"10.1016\/j.scr.2015.09.016_bb0195","first-page":"261","article-title":"Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells","volume":"22","author":"Takahira","year":"1994","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.scr.2015.09.016_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<129::AID-AJH1>3.0.CO;2-J","article-title":"The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the national sickle cell surgery study group","volume":"62","author":"Vichinsky","year":"1999","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.scr.2015.09.016_bb0205","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3928\/01477447-20080501-33","article-title":"Decreased proliferation of mesenchymal stem cells in corticosteroid-induced osteonecrosis of femoral head","volume":"31","author":"Wang","year":"2008","journal-title":"Orthopedics"},{"issue":"3\u20134","key":"10.1016\/j.scr.2015.09.016_bb0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/ten.tea.2011.0315","article-title":"Improved mesenchymal stem cells attachment and in vitro cartilage tissue formation on chitosan-modified poly(L-lactide-co-epsilon-caprolactone) scaffold","volume":"18","author":"Yang","year":"2012","journal-title":"Tissue Eng. A"}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506115001361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506115001361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T21:15:31Z","timestamp":1599686131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506115001361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1873506115001361"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2015.09.016","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2015.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}